查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
诱导多能干细胞 (iPSC) 市场：按细胞衍生、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、预测 2023-2030
市场调查报告书
商品编码
1290848

诱导多能干细胞 (iPSC) 市场：按细胞衍生、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、预测 2023-2030

Induced Pluripotent Stem Cell (iPSC) Market with COVID-19 Impact Analysis, By Derived Cell, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 402 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年诱导多能干细胞 (iPSC) 市场规模将达到 20.053 亿美元，2023 年至 2030 年復合年增长率为 7.1%

诱导多能干细胞 (iPSC) 市场 - 市场动态

对疫苗生产的需求不断增长，特别是在大流行之后，以及对 iPSC 领域投资的增加是推动 iPSC 市场快速增长的一些因素。

这次大流行还凸显了基于细胞的疗法对疾病治疗的重要性。iPSC 提供了可再生的细胞来源，可以分化为用于治疗应用的各种细胞类型。这包括可能使用 iPSC 开发基于细胞的疗法来治疗肺损伤等与 COVID-19 相关的并发症。根据世界卫生组织的数据，慢性阻塞性肺疾病（COPD）是全球第三大死亡原因，2019 年有 323 万人死亡。许多政府已经认识到 iPSC 技术的潜力，并启动了资助计划来支持研究和商业化工作。iPSC 衍生细胞为疫苗生产提供了一致且可扩展的平台，从而实现更快、更高效的疫苗生产过程。

诱导多能干细胞 (iPSC) 市场 - 关键见解

  • 根据我们的研究分析师的分析，全球诱导多能干细胞（iPSC）市场预计在预测期内（2023-2030年）每年都会显着增长。
  • 由于可持续增长意识的增强，预计诱导多能干细胞 (iPSC) 行业将大幅增长
  • 按类型细分，预计心肌细胞将在 2022 年占据最大的市场份额
  • 从应用来看，药物开发和发现将成为2022年的主要市场。
  • 按地区划分，北美将成为 2022 年最大的收入来源。

诱导多能干细胞 (iPSC) 市场细分分析：

全球诱导多能干细胞（iPSC）市场根据细胞来源、应用和地区进行细分。

市场根据细胞来源分为三类：肝细胞、成纤维细胞。肝细胞、成纤维细胞、羊水细胞、心肌细胞等。心肌细胞在市场上占据主导地位。患者特异性 iPSC 衍生心肌细胞 (iPSC-CM) 对于心血管疾病建模、研究人类发育的早期阶段、加速药物毒性预测测试以及潜在推进再生疗法提供了一个实验平台。

市场按应用分为两类：製造、学术研究、药物开发和发现、毒性筛查和再生医学。药物开发和发现在市场中占据主导地位，预计在预测期内将保持其主导地位。诱导多能干细胞 (iPSC) 技术正在彻底改变医学，使我们能够探索疾病机制和新的治疗分子靶点，并为药物发现和药物开发的概念验证研究提供机会。

诱导多能干细胞 (iPSC) 市场 - 地理洞察

从地理上看，该市场遍布北美、拉丁美洲、欧洲、亚太地区、中东和非洲。由于慢性病的流行以及干细胞在治疗中的使用，预计北美将主导诱导多能干细胞（iPSC）市场。根据美国疾病控制与预防中心的数据，2018 年，普通人群中 51.8%（1.29 亿）的非住院成年人至少患有 10 种选定的慢性病中的一种。对解决慢性病的先进和创新疗法的需求正在推动该地区 iPSC 市场的增长。总体而言，欧洲和亚洲也积极参与 iPSC 研发。

诱导多能干细胞 (iPSC) 市场 - 竞争格局：

美国、韩国、日本、英国和中国已成为干细胞治疗的前五个国家，因为它们愿意推进该领域并为患者提供创新治疗。iPS 细胞市场的知名企业只是其中的几个例子。全球其他公司、学术机构和研究机构也积极从事iPS细胞研究、产品开发和临床试验。例如，2021 年 1 月 27 日，Thermo Fisher Scientific 使用同种异体工作流程为细胞疗法开发人员开发了一种用于人类 T 淋巴细胞 (T 细胞) 发育和扩增的新培养基。新产品发布、分销网络开发、研发支出以及併购是公司扩大影响力和市场份额的一些关键方法。

最近的发展

2021 年 11 月，人类 iPS 细胞（诱导多能干细胞）技术领先公司 Ncardia（比利时戈斯利）宣布与投资平台 Kiniciti（美国纽约）建立合作伙伴关係。

研究的主要特点

  • 本研究报告提供了以2022年为基准年的诱导多能干细胞（iPSC）市场规模、复合年增长率、市场估计和预测（2023-2030年）。
  • 该研究报告让客户深入了解诱导多能干细胞 (iPSC) 市场的最新趋势。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并描述了诱导多能干细胞 (iPSC) 市场有吸引力的投资主张矩阵。
  • 综合报告揭示了诱导多能干细胞 (iPSC) 市场的新投资机会、现有企业面临的挑战以及持续增长动力
  • 研究范围详细讨论了 COVID-19 对诱导多能干细胞 (iPSC) 市场规模、预测、复合年增长率和市场动态的影响。它还涵盖了对新冠疫情后诱导多能干细胞 (iPSC) 市场的深入见解。
  • 为了向本报告的用户提供诱导多能干细胞（iPSC）市场的全面了解，还包括诱导多能干细胞（iPSC）市场的竞争格局和关键创新者分析。
  • 该研究涵盖了增长前景映射分析，并根据市场规模、增长率和吸引力对所有行业领域进行了基准测试。
  • 该报告提供了主要市场进入者的详细公司概况，有助于了解在诱导多能干细胞 (iPSC) 市场运营的公司的财务信息和战略举措。
  • 此外，报告还揭示了全球和区域市场主要参与者的重大收购和兼併、合作和合资、初创企业、研发和区域扩张。
  • 本研究报告主要面向该行业的各个利益相关者，如供应商、投资者、新进入者、分销商和财务分析师。

目录

第一章诱导多能干细胞（iPSC）市场概述

  • 调查范围

第二章执行摘要

  • 市场细分
  • 竞争考虑

第三章诱导多能干细胞（iPSC）的主要市场趋势

  • 市场驱动力
  • 诱导多能干细胞（iPSC）市场限制因素
  • 诱导多能干细胞 (iPSC) 的市场机会
  • 诱导多能干细胞（iPSC）市场的未来趋势

第 4 章 诱导多能干细胞 (iPSC) 行业调查

  • PEST分析
  • 波特五力分析
  • 绘製增长前景
  • 监管框架分析

第五章诱导多能干细胞（iPSC）市场：COVID-19 的影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析

第六章诱导多能干细胞（iPSC）市场格局

  • 诱导多能干细胞 (iPSC) 市场份额分析，2022 年
  • 主要製造商的细分数据
    • 现有公司分析
    • 启动分析

7.诱导多能干细胞（iPSC）市场——按细胞衍生

  • 概述
    • 细分市场份额分析（按衍生单元）
    • 标准钢诱导多能干细胞 (iPSC)
    • 非磁性诱导多能干细胞（iPSC）

8 诱导多能干细胞 (iPSC) 市场 - 按应用

  • 概述
    • 按应用划分的细分市场份额分析
    • 土地
    • 离岸

第九章诱导多能干细胞 (iPSC) 市场 - 按地区

  • 介绍
  • 北美
    • 概述
    • 北美领先的诱导多能干细胞 (iPSC) 製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲领先的诱导多能干细胞 (iPSC) 製造商
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区领先的诱导多能干细胞 (iPSC) 製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲领先的诱导多能干细胞 (iPSC) 製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概述
    • 中东和非洲领先的诱导多能干细胞 (iPSC) 製造商
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第10章主要供应商分析-诱导多能干细胞（iPSC）行业

  • 比赛仪表板
  • 公司简介
    • Lonza
    • Axol Biosciences Ltd.
    • Evotec SE
    • Hitachi Ltd.
    • Merck KGaA
    • REPROCELLS, Inc.
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • StemCellsFactory III
    • Applied StemCells, Inc.

第十一章 分析师的全面看法

Product Code: ANV1294

REPORT HIGHLIGHT

Induced Pluripotent Stem Cell (iPSC) Market size was valued at USD 2,005.3 million in 2022, expanding at a CAGR of 7.1% from 2023 to 2030.

Induced Pluripotent Stem cells (iPSC) are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient, or neurons to treat neurological disorders. iPSC have certain advantages over other stem cell types in models of regenerative medicine and wound healing. Because they are derived from adult somatic cells, and not embryos, iPSC are not associated with the ethical dilemmas surrounding the use of embryonic stem cells.

Induced Pluripotent Stem Cell (iPSC) Market- Market Dynamics:

Rising demand for vaccine production especially after the onslaught of the pandemic, and increasing investments in the iPSC sector are some of the factors contributing towards rapid iPSC market growth.

The pandemic has also emphasized the importance of cell-based therapies for treating diseases. iPSCs offer a renewable source of cells that can be differentiated into various cell types for therapeutic applications. This includes the potential use of iPSCs for developing cell-based therapies to treat COVID-19-related complications, such as lung damage. According to World health organization, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Many governments recognize the potential of iPSC technology and have initiated funding programs to support research and commercialization efforts. iPSC-derived cells provide a consistent and scalable platform for vaccine production, enabling faster and more efficient vaccine manufacturing processes.

Induced Pluripotent Stem Cell (iPSC) Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Induced Pluripotent Stem Cell (iPSC) market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Induced Pluripotent Stem Cell (iPSC) industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on type segmentation, Cardiomyocytes were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Drug development, and discovery were the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Induced Pluripotent Stem Cell (iPSC) Market- Segmentation Analysis:

  • The Global Induced Pluripotent Stem Cell (iPSC) Market is segmented on the basis of derived cells, Application, and Region.
  • The market is divided into three categories based on derived cells: Hepatocytes, Fibroblasts. Amniotic Cells, Cardiomyocytes, and Others. Cardiomyocytes dominate the market. Patient-specific iPSC-derived Cardiomyocytes (iPSC-CMs) offer an attractive experimental platform to model cardiovascular diseases, study the earliest stages of human development, accelerate predictive drug toxicology tests, and advance potential regenerative therapies.
  • The market is divided into two categories based on application: Manufacturing, Academic Research, Drug Development & Discovery, Toxicity Screening, and Regenerative Medicine. Drug development and discovery dominate the market and are likely to maintain its dominance during the forecast period. Induced pluripotent stem cell (iPSC) technology is revolutionizing medical science, allowing the exploration of disease mechanisms and novel therapeutic molecular targets, and offering opportunities for drug discovery and proof-of-concept studies in drug development.

Induced Pluripotent Stem Cell (iPSC) Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to dominate the Induced Pluripotent Stem Cell (iPSC market, due to the prevalence of chronic disease and the use of Stem Cell in their treatment. According to center of disease control and prevention, in 2018, 51.8% (129 million) of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. iPSCs hold tremendous potential for developing personalized therapies and disease modeling in these areas. The demand for advanced treatments and innovative therapies to address chronic diseases drives the growth of the iPSC market in this region. Overall, Europe and Asia, are also actively participating in iPSC research and development.

Induced Pluripotent Stem Cell (iPSC) Market- Competitive Landscape:

The United States, South Korea, Japan, the United Kingdom, and China have emerged as the top five countries for stem cell treatment, recognitions to their commitment to advancing the field and providing innovative treatment options for patients. There are just a few examples of prominent players in the iPSC market. Other companies, academic institutions, and research organizations worldwide are actively engaged in iPSC research, product development, and clinical trials. For example, 27 Jan,2021 Thermo Fisher Scientific has developed a new medium for the development and expansion of human T lymphocytes (T-cells) for cell therapy developers using allogeneic workflows. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions.

Recent Developments:

In November 2021, Ncardia (Gosselies, Belgium), a leading human-induced pluripotent stem cell (iPSC) technology company, has recently announced their partnership with investment platform Kiniciti (NY, USA) - a collaboration which will facilitate the development of innovative iPSC-derived advanced therapies.

Key features of the study:

  • This proposed research study on Induced Pluripotent Stem Cell (iPSC) market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Induced Pluripotent Stem Cell (iPSC) market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Induced Pluripotent Stem Cell (iPSC) market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Induced Pluripotent Stem Cell (iPSC) market
  • Impact of COVID-19 on Induced Pluripotent Stem Cell (iPSC) market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Induced Pluripotent Stem Cell (iPSC) market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Induced Pluripotent Stem Cell (iPSC) market, we have also included competitive landscape and key innovator analysis for the Induced Pluripotent Stem Cell (iPSC) market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Induced Pluripotent Stem Cell (iPSC) market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Induced Pluripotent Stem Cell (iPSC) market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET KEY PLAYERS

  • Lonza
  • Axol Biosciences Ltd.
  • Evotec SE
  • Hitachi Ltd.
  • Merck KGaA
  • REPROCELLS, Inc.
  • Fate Therapeutics
  • Thermo Fisher Scientific, Inc.
  • StemCellsFactory III
  • Applied StemCells, Inc.

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY DERIVED CELL

  • Hepatocytes
  • Fibroblasts
  • Amniotic Cells
  • Cardiomyocytes
  • Others

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY APPLICATION

  • Manufacturing
  • Academic Research
  • Drug Development & Discovery
  • Toxicity Screening
  • Regenerative Medicine

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Induced Pluripotent Stem Cell (iPSC) Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Derived Cells
    • 2.1.2. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Application
    • 2.1.3. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Country
    • 2.1.4. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Region
  • 2.2. Competitive Insights

3. Induced Pluripotent Stem Cell (iPSC) Key Market Trends

  • 3.1. Induced Pluripotent Stem Cell (iPSC) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Induced Pluripotent Stem Cell (iPSC) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Induced Pluripotent Stem Cell (iPSC) Market Opportunities
  • 3.4. Induced Pluripotent Stem Cell (iPSC) Market Future Trends

4. Induced Pluripotent Stem Cell (iPSC) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Induced Pluripotent Stem Cell (iPSC) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Induced Pluripotent Stem Cell (iPSC) Market Landscape

  • 6.1. Induced Pluripotent Stem Cell (iPSC) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Induced Pluripotent Stem Cell (iPSC) Market - By Derived cells

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Derived cells, 2022 & 2030 (%)
    • 7.1.2. Standard Steel Induced Pluripotent Stem Cell (iPSC)
    • 7.1.3. Non-magnetic Induced Pluripotent Stem Cell (iPSC)

8. Induced Pluripotent Stem Cell (iPSC) Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Onshore
    • 8.1.3. Offshore

9. Induced Pluripotent Stem Cell (iPSC) Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Induced Pluripotent Stem Cell (iPSC) Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Lonza
    • 10.2.2. Axol Biosciences Ltd.
    • 10.2.3. Evotec SE
    • 10.2.4. Hitachi Ltd.
    • 10.2.5. Merck KGaA
    • 10.2.6. REPROCELLS, Inc.
    • 10.2.7. Fate Therapeutics
    • 10.2.8. Thermo Fisher Scientific, Inc.
    • 10.2.9. StemCellsFactory III
    • 10.2.10. Applied StemCells, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Derived cells Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Derived cells
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Application 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Induced Pluripotent Stem Cell (iPSC) Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Derived cells segment market share analysis, 2022 & 2030
  • FIGURE Derived cells segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Germany Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE India Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Brazil Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)